Enzyme.Myso Leads Onchain Options Revolution with $1.2M Aave Call
Enzyme.Myso Leads Onchain Options Revolution with $1.2M Aave Call
馃幆 Options Just Got Spicy
Tokenized options are gaining momentum in DeFi as projects move beyond basic tokenized products. Enzyme.Myso is at the forefront of this evolution:
- $1.2M call option on Aave executed entirely onchain
- Compound DAO implements covered call strategy targeting ~15% APY
- Treasuries and DAOs leveraging custom options to activate idle assets
The platform enables bespoke onchain options strategies including covered calls and cash-secured puts, offering organizations new ways to deploy capital efficiently.
Options are joining the wave of tokenized financial instruments. As teams look beyond first-generation tokenized products, they鈥檙e starting to rebuild strategies directly onchain, using instruments like calls and puts to deploy capital with precision. Enzyme.Myso聽is powering
Enzyme Launches Two-Tier Infrastructure for Real World Assets
Enzyme has introduced two key solutions for bringing real-world assets (RWAs) onchain: - **Enzyme.Blue**: An all-in-one vault platform offering comprehensive tokenized finance capabilities - **Enzyme.Onyx**: A wallet tokenization layer that integrates with existing custody solutions This launch comes amid significant growth in RWA tokenization, with Binance reporting a 260% market expansion to $23B in H1 2025. The infrastructure supports both traditional fund tokenization and native onchain fund creation. Citi projects tokenized securities could reach $45T by 2030, while WEF estimates 10% of global GDP could be tokenized by 2027. [Learn more about Enzyme's RWA solutions](https://enzyme.finance/use-cases/rwa)
Tokenized Securities Market Projected to Reach $45T by 2030
Major financial institutions are forecasting significant growth in tokenized assets: - Citi projects tokenized securities market could reach $45T by 2030 - WEF estimates 10% of global GDP could be blockchain-tokenized by 2027 - McKinsey reports shift from pilot to at-scale deployment Key trends expected in next cycle: - Shift to natively tokenized funds - Increased institutional adoption - Integration with DeFi infrastructure - Clearer regulatory framework Traditional finance faces challenges from outdated systems, while tokenized vehicles offer programmability and global accessibility. Enzyme Protocol is positioning to support this transition with native tokenization capabilities. [Learn more about tokenized funds](http://enzyme.finance/use-cases/tokenized-funds)
Tokenized Real-World Assets Hit Major Milestone
Real-world assets (RWAs) tokenized on blockchain have reached a significant milestone, surpassing $10B in Total Value Locked (TVL). This marks a crucial shift in how traditional assets are being brought on-chain. Key developments: - Over $18B in assets now tokenized (excluding stablecoins) - Infrastructure development becoming priority for operational use - Integration possibilities include RWA funds, ETPs, and indices Enzyme Protocol enables users to leverage these tokenized assets within investment strategies, marking a practical step toward mainstream RWA adoption. Learn more about tokenized asset infrastructure: [Chainlink's Guide](https://blog.chain.link/definitive-guide-to-tokenized-assets/)
Enzyme Acquires Myso Finance and Expands to Solana in Major 2024 Growth
Enzyme Protocol marked significant expansion in 2024 with key developments: - Acquired Myso Finance, the leading on-chain covered calls protocol - Invested in Trade Neutral to expand services to Solana ecosystem - Extended protocol to Arbitrum and integrated GMX - Launched first Advanced Automated Loops with Stader Labs - Reached $220M in Assets Under Technology with 1,400+ creations 2025 roadmap focuses on: - Completing Solana integration - Expanding to additional networks - Launching V5 protocol update - Strengthening global infrastructure position The protocol has maintained steady growth since its 2017 launch as Melon Protocol, navigating market cycles while expanding capabilities.